Dr. Jay Skyler, MD

Internal Medicine Miami, FL Male
NPI: 1437114691
Total Payments
$2.9M
2024 Payments
$70,238
Companies
20
Transactions
247

Payment Breakdown by Category

Other$1.6M (56.2%)
Consulting$1.1M (38.3%)
Travel$128,668 (4.5%)
Research$22,950 (0.8%)
Food & Beverage$7,882 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1.1M 55 38.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $660,485 9 22.9%
Current or prospective ownership or investment interest $646,586 6 22.4%
Grant $311,268 1 10.8%
Travel and Lodging $128,668 96 4.5%
Unspecified $22,950 4 0.8%
Food and Beverage $7,882 76 0.3%

Payments by Type

General
$2.9M
243 transactions
Research
$22,950
4 transactions

Top Paying Companies

Company Total Records Latest Year
Dexcom, Inc. $2.5M 55 $0 (2023)
SANOFI-AVENTIS U.S. LLC $287,704 82 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $31,130 28 $0 (2020)
Bayer Healthcare Pharmaceuticals Inc. $28,531 28 $0 (2024)
Eli Lilly and Company $18,683 8 $0 (2024)
Boehringer Ingelheim International GmbH $16,386 7 $0 (2020)
Novo Nordisk AS $12,500 7 $0 (2024)
Novo Nordisk Inc $11,747 13 $0 (2024)
ABBVIE INC. $8,525 1 $0 (2024)
VERTEX PHARMACEUTICALS INCORPORATED $2,730 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $70,238 35 SANOFI-AVENTIS U.S. LLC ($25,467)
2023 $492,730 21 Dexcom, Inc. ($471,344)
2022 $371,696 24 Dexcom, Inc. ($327,094)
2021 $339,214 10 DEXCOM, INC. ($307,881)
2020 $365,817 14 Dexcom, Inc. ($339,333)
2019 $458,899 66 Dexcom, Inc. ($341,390)
2018 $399,640 43 Dexcom, Inc. ($347,642)
2017 $381,948 34 Dexcom, Inc. ($323,128)

All Payment Transactions

247 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/05/2024 Novo Nordisk Inc — Food and Beverage In-kind items and services $20.91 General
11/04/2024 VERTEX PHARMACEUTICALS INCORPORATED — Consulting Fee Cash or cash equivalent $315.00 General
10/21/2024 VERTEX PHARMACEUTICALS INCORPORATED — Consulting Fee Cash or cash equivalent $1,215.00 General
08/22/2024 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $1,430.00 General
08/22/2024 SANOFI-AVENTIS U.S. LLC TOUJEO (Biological) Consulting Fee Cash or cash equivalent $715.00 General
Category: Endocrine & Metabolic Diseases
08/22/2024 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $715.00 General
08/05/2024 Eli Lilly and Company — Consulting Fee Cash or cash equivalent $2,500.00 General
07/18/2024 ABBVIE INC. — Consulting Fee Cash or cash equivalent $8,525.00 General
06/20/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Consulting Fee Cash or cash equivalent $17,667.00 General
Category: Endocrine & Metabolic Diseases
06/20/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Travel and Lodging In-kind items and services $1,635.25 General
Category: Endocrine & Metabolic Diseases
06/20/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Travel and Lodging In-kind items and services $859.28 General
Category: Endocrine & Metabolic Diseases
06/20/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Travel and Lodging In-kind items and services $677.26 General
Category: Endocrine & Metabolic Diseases
06/20/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Food and Beverage In-kind items and services $338.33 General
Category: Endocrine & Metabolic Diseases
05/13/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) — Cash or cash equivalent $8,400.00 Research
Study: 22267 - Dr. Jay S. Sklyer Steering Committee • Category: Cardio-renal
04/25/2024 VERTEX PHARMACEUTICALS INCORPORATED — Consulting Fee Cash or cash equivalent $1,200.00 General
03/16/2024 Novo Nordisk AS — Consulting Fee Cash or cash equivalent $6,955.00 General
03/16/2024 Novo Nordisk AS — Food and Beverage In-kind items and services $205.45 General
03/16/2024 Novo Nordisk AS — Travel and Lodging In-kind items and services $32.16 General
03/16/2024 Novo Nordisk AS — Travel and Lodging In-kind items and services $5.00 General
03/15/2024 Novo Nordisk AS — Consulting Fee Cash or cash equivalent $2,242.50 General
03/14/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Travel and Lodging In-kind items and services $3,196.99 General
Category: Cardio-renal
03/14/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Travel and Lodging In-kind items and services $190.00 General
Category: Cardio-renal
03/14/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $95.48 General
Category: Cardio-renal
03/14/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Travel and Lodging In-kind items and services $77.03 General
Category: Cardio-renal
03/14/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $50.00 General
Category: Cardio-renal
123…10»

Research Studies & Clinical Trials

Study Name Company Amount Records
22267 - Dr. Jay S. Sklyer Steering Committee Bayer Healthcare Pharmaceuticals Inc. $10,200 2
A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus SANOFI US SERVICES INC. $1,950 1

About Dr. Jay Skyler, MD

Dr. Jay Skyler, MD is a Internal Medicine healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437114691.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Skyler, MD has received a total of $2.9M in payments from pharmaceutical and medical device companies, with $70,238 received in 2024. These payments were reported across 247 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($1.1M).

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Diabetes & Metabolism
  • Location Miami, FL
  • Active Since 04/19/2006
  • Last Updated 10/31/2023
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1437114691

Products in Payments

  • Dexcom CGM (Device) $347,642
  • DEXCOM CGM (Device) $340,404
  • DEXCOM G6 CGM SYSTEM (Device) $339,333
  • Dexcom G6 Transmitter (Medical Supply) $327,094
  • Dexcom G5 Mobile CGM System (Device) $323,128
  • DEXCOM G6 TRANSMITTER (Device) $307,881
  • NO PRODUCT DISCUSSED (Drug) $97,954
  • JARDIANCE (Drug) $52,428
  • TOUJEO (Drug) $52,100
  • TOUJEO (Biological) $43,897
  • SOLIQUA 100/33 (Biological) $30,257
  • Kerendia (Drug) $26,064
  • TZIELD (Biological) $23,127
  • SOTAGLIFLOZIN (Drug) $15,521
  • SOLIQUA (Drug) $10,028
  • LANTUS (Biological) $6,630
  • Non-Covered $2,467
  • FARXIGA (Drug) $1,343
  • Livalo (Drug) $121.77
  • Victoza (Drug) $118.34

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Miami

Dr. Lukasz Kwapisz

Internal Medicine — Payments: $800,664

Internal Medicine $800,664

Mark Kutner, Md, MD

Internal Medicine — Payments: $610,516

Internal Medicine $610,516

Dr. Ian Del Conde Pozzi, M.d, M.D

Internal Medicine — Payments: $499,756

Internal Medicine $499,756

Mr. Angel Carrasco, M.d, M.D

Internal Medicine — Payments: $493,362

Internal Medicine $493,362

Dr. Edward Mezerhane, Md, MD

Internal Medicine — Payments: $470,504

Internal Medicine $470,504

Joanna Lopez, Md, MD

Internal Medicine — Payments: $435,514

Internal Medicine $435,514